Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice-Reference-Cited by-同舟云学术

Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice

Published:2017-04-12 Issue:7650 Volume:544 Page:367-371
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Becker Lindsay A.,Huang Brenda,Bieri Gregor,Ma Rosanna,Knowles David A.,Jafar-Nejad Paymaan,Messing James,Kim Hong Joo,Soriano Armand,Auburger Georg,Pulst Stefan M.,Taylor J. Paul,Rigo Frank,Gitler Aaron D.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature22038.pdf

Reference35 articles.

1. Taylor, J. P., Brown, R. H., Jr & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197–206 (2016)

2. Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133 (2006)

3. Lagier-Tourenne, C. & Cleveland, D. W. Rethinking ALS: the FUS about TDP-43. Cell 136, 1001–1004 (2009)

4. Southwell, A. L., Skotte, N. H., Bennett, C. F. & Hayden, M. R. Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases. Trends Mol. Med. 18, 634–643 (2012)

5. Smith, R. A. et al. Antisense oligonucleotide therapy for neurodegenerative disease. J. Clin. Invest. 116, 2290–2296 (2006)

Cited by 441 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IntermediateHTTCAG repeats worsen disease severity in amyotrophic lateral sclerosis;Journal of Neurology, Neurosurgery & Psychiatry;2024-09-06

2. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies;Ageing Research Reviews;2024-09

3. ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes;Nature Communications;2024-08-29

4. The genetics of amyotrophic lateral sclerosis;Current Opinion in Neurology;2024-08-22

5. Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update;Expert Opinion on Drug Discovery;2024-08-08